{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:51:19Z","timestamp":1781772679095,"version":"3.54.5"},"reference-count":98,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Treating autosomal dominant polycystic kidney disease (ADPKD) has always been a challenge because the disease is too complex for single-target drugs, which are often held back by side effects. This narrative review explores a different strategy: using plant-derived polyphenols to target multiple disease pathways at the same time. Looking at research from 2005 to 2026, we break down how key compounds like resveratrol, curcumin, naringenin, quercetin, and epigallocatechin-3-gallate (EGCG) actually work. Preclinical studies show these molecules can slow down cyst growth by tackling inflammation, rapid cell division, and tissue scarring all at once, while also resetting the skewed energy metabolism of cystic cells. Some mechanisms are strikingly specific, such as naringenin\u2019s direct interaction with polycystin-2 and quercetin\u2019s ability to clear senescent cells. Yet, the real-world hurdle is poor absorption; a recent clinical trial with standard curcumin fell short simply because the compound could not reach the kidneys in high enough concentrations. Moving forward, the field needs to focus on testing these compounds in realistic animal models, designing smart nanoformulations to improve bioavailability, and exploring combinations that could safely complement current therapies like tolvaptan.<\/jats:p>","DOI":"10.3390\/life16061022","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:33:54Z","timestamp":1781768034000},"page":"1022","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polyphenols and ADPKD: A Further Aid from Nature?"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-8823","authenticated-orcid":false,"given":"Caterina","family":"Carollo","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-3616","authenticated-orcid":false,"given":"Alessandra","family":"Sorce","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8245-9219","authenticated-orcid":false,"given":"Maria Elena","family":"Ciuppa","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4934-0818","authenticated-orcid":false,"given":"Emanuele","family":"Cirafici","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0430-4682","authenticated-orcid":false,"given":"Nicola","family":"Sinatra","sequence":"additional","affiliation":[{"name":"UOSD Nefrologia e Dialisi, Ospedale Paolo Borsellino, 91025 Marsala, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-1151","authenticated-orcid":false,"given":"Giulio","family":"Geraci","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, \u201cKore\u201d University of Enna, 94100 Enna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5177-320X","authenticated-orcid":false,"given":"Valentina","family":"Patern\u00f2","sequence":"additional","affiliation":[{"name":"Operative Unit of Diabetology, Umberto I Hospital, Provincial Health Authority (ASP) of Enna, 94100 Enna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4418-5855","authenticated-orcid":false,"given":"Paola","family":"Di Carlo","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7491-568X","authenticated-orcid":false,"given":"Rosalia Lo","family":"Presti","sequence":"additional","affiliation":[{"name":"Department of Psychology, Educational Science and Human Movement, University of Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8500-8671","authenticated-orcid":false,"given":"Giuseppe","family":"Mul\u00e8","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Caimi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Carollo, C., Sorce, A., Cirafici, E., Mul\u00e8, G., and Caimi, G. (2025). Sirtuins and Resveratrol in Cardiorenal Diseases: A Narrative Review of Mechanisms and Therapeutic Potential. Nutrients, 17.","DOI":"10.20944\/preprints202503.1085.v1"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Carollo, C., Ciuppa, M.E., Sorce, A., Evola, S., Cirafici, E., Vario, M.G., Scimeca, R., Presti, R.L., Mul\u00e8, G., and Caimi, G. (2026). Nature\u2019s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads\u2014Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection. Nutrients, 18.","DOI":"10.3390\/nu18060955"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/j.ajkd.2025.05.010","article-title":"Autosomal Dominant Polycystic Kidney Disease: Core Curriculum","volume":"86","author":"Gordon","year":"2025","journal-title":"Am. J. Kidney Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"(2025). Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int., 107, S1\u2013S239.","DOI":"10.1016\/j.kint.2024.07.009"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Solazzo, A., Testa, F., Giovanella, S., Busutti, M., Furci, L., Carrera, P., Ferrari, M., Ligabue, G., Mori, G., and Leonelli, M. (2018). The prevalence of ADPKD: A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190430"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-981-10-2041-4_4","article-title":"Inflammation and Fibrosis in ADPKD","volume":"933","author":"Mun","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Grosso, G., Godos, J., Currenti, W., Micek, A., Falzone, L., Libra, M., Giampieri, F., Forbes-Hern\u00e1ndez, T.Y., Quiles, J.L., and Battino, M. (2022). The Effect of Dietary Polyphenols on Vascular Health and Hypertension: Current Evidence and Mechanisms of Action. Nutrients, 14.","DOI":"10.3390\/nu14030545"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ma, Y., Wang, J., Fan, J., Jia, H., and Li, J. (2024). Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy. Molecules, 30.","DOI":"10.3390\/molecules30010020"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tovar-Palacio, C., Noriega, L.G., and Mercado, A. (2022). Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease. Nutrients, 14.","DOI":"10.3390\/nu14030653"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, Encoding the Glucosidase II\u03b1 Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease","volume":"102","author":"Olson","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.2022.22847","article-title":"Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease","volume":"328","author":"Chang","year":"2022","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI5111","article-title":"Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins","volume":"104","author":"Huan","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.1073\/pnas.252484899","article-title":"Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations","volume":"99","author":"Qian","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/MCB.00687-14","article-title":"Novel functional complexity of polycystin-1 by GPS cleavage in vivo: Role in polycystic kidney disease","volume":"34","author":"Kurbegovic","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","article-title":"Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease","volume":"10","author":"Low","year":"2006","journal-title":"Dev. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1113\/JP270933","article-title":"Structural studies of the C-terminal tail of polycystin-2 (PC2) reveal insights into the mechanisms used for the functional regulation of PC2","volume":"594","author":"Yang","year":"2016","journal-title":"J. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/35050128","article-title":"Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents","volume":"408","author":"Hanaoka","year":"2000","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1152\/physrev.00018.2024","article-title":"Physiologic mechanisms underlying polycystic kidney disease","volume":"105","author":"Boletta","year":"2025","journal-title":"Physiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Reiterov\u00e1, J., and Tesa\u0159, V. (2022). Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063317"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Al-Orjani, Q., Alshriem, L.A., Gallagher, G., Buqaileh, R., Azizi, N., and AbouAlaiwi, W. (2025). Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. Cells, 14.","DOI":"10.3390\/cells14151203"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and Fibrosis in Polycystic Kidney Disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl. Cell Differ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease","volume":"222","author":"Hassane","year":"2010","journal-title":"J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.ASN.0000103225.68136.E6","article-title":"Activin A is a potent activator of renal interstitial fibroblasts","volume":"15","author":"Yamashita","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1681\/ASN.2015030287","article-title":"Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease","volume":"27","author":"Leonhard","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.kint.2022.08.036","article-title":"Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease","volume":"103","author":"Dwivedi","year":"2023","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Podrini, C., Cassina, M., and Boletta, A. (2022). AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target. Front. Med., 9.","DOI":"10.3389\/fmed.2022.753418"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Riwanto, M., Kapoor, S., Rodriguez, D., Edenhofer, I., Segerer, S., and W\u00fcthrich, R.P. (2016). Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146654"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s42003-018-0200-x","article-title":"Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways","volume":"1","author":"Podrini","year":"2018","journal-title":"Commun. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stankovic, S., Mutavdzin Krneta, S., Djuric, D., Milosevic, V., and Milenkovic, D. (2025). Plant Polyphenols as Heart\u2019s Best Friends: From Health Properties, to Cellular Effects, to Molecular Mechanisms of Action. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030915"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Stromsnes, K., Lagzdina, R., Olaso-Gonzalez, G., Gimeno-Mallench, L., and Gambini, J. (2021). Pharmacological Properties of Polyphenols: Bioavailability, Mechanisms of Action, and Biological Effects in In Vitro Studies, Animal Models, and Humans. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081074"},{"key":"ref_44","first-page":"348","article-title":"Polyphenols, dietary sources and bioavailability","volume":"43","author":"Filesi","year":"2007","journal-title":"Ann. Ist. Super. Sanit\u00e0"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2010.02.071","article-title":"Antioxidants: Molecules, medicines, and myths","volume":"393","author":"Gutteridge","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Guerrero, L., Castillo, J., Qui\u00f1ones, M., Garcia-Vallv\u00e9, S., Arola, L., Pujadas, G., and Muguerza, B. (2012). Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049493"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1017\/S0029665110000054","article-title":"Beyond antioxidants: The cellular and molecular interactions of flavonoids and how these underpin their actions on the brain","volume":"69","author":"Spencer","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Riillo, C., Parafati, M., Crupi, F., Fotschki, B., Ragusa, M., Di Vito, A., Mignogna, C., Mollace, V., and Janda, E. (2025). Bergamot Polyphenols Reduce Hepatic Lipogenesis While Boosting Autophagy and Short-Chain Fatty Acid Production in a Murine \u2018Cafeteria\u2019 Model of MASLD. Nutrients, 17.","DOI":"10.3390\/nu17233684"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.fitote.2010.10.014","article-title":"Hypolipemic and hypoglycaemic activity of bergamot polyphenols: From animal models to human studies","volume":"82","author":"Mollace","year":"2011","journal-title":"Fitoterapia"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Vargas, F., Romec\u00edn, P., Garc\u00eda-Guill\u00e9n, A.I., Wangesteen, R., Vargas-Tendero, P., Paredes, M.D., Atucha, N.M., and Garc\u00eda-Esta\u00f1, J. (2018). Flavonoids in Kidney Health and Disease. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00394"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.290.8.1030","article-title":"Vascular effects of cocoa rich in flavan-3-ols","volume":"290","author":"Heiss","year":"2003","journal-title":"JAMA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10157-021-02111-x","article-title":"Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment","volume":"25","author":"Mahendran","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, J., Chen, J., Xu, J., Xue, C., and Mao, Z. (2023). Plant-derived compounds for treating autosomal dominant polycystic kidney disease. Front. Nephrol., 3.","DOI":"10.3389\/fneph.2023.1071441"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13197-013-0993-z","article-title":"Resveratrol content and antioxidant properties of underutilized fruits","volume":"52","author":"Shrikanta","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/10408398.2011.606928","article-title":"Resveratrol in peanuts","volume":"54","author":"Sales","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1021\/jf0112973","article-title":"Plant foods and herbal sources of resveratrol","volume":"50","author":"Burns","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jss.2005.10.010","article-title":"Possible role of nitric oxide in the protective effect of resveratrol in 5\/6th nephrectomized rats","volume":"133","author":"Chander","year":"2006","journal-title":"J. Surg. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arcmed.2005.05.018","article-title":"Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats","volume":"37","author":"Chander","year":"2006","journal-title":"Arch. Med. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1096\/fj.08-109488","article-title":"Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: Role of PTP1B","volume":"22","author":"Venkatesan","year":"2008","journal-title":"FASEB J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biocel.2012.01.001","article-title":"High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK\/NF-\u03baB\/NADPH oxidase\/ROS pathway, which is inhibited by resveratrol","volume":"44","author":"Zhang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.acthis.2017.04.002","article-title":"Resveratrol improves mitochondrial function in the remnant kidney from 5\/6 nephrectomized rats","volume":"119","author":"Hui","year":"2017","journal-title":"Acta Histochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1210\/me.2015-1277","article-title":"HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db\/db Mice","volume":"30","author":"Yan","year":"2016","journal-title":"Mol. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.prp.2016.02.001","article-title":"Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat","volume":"212","author":"Ma","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/ndt\/gfw058","article-title":"Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor \u03baB-induced inflammation","volume":"31","author":"Wu","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1152\/ajpendo.00285.2017","article-title":"Curcumin and other dietary polyphenols: Potential mechanisms of metabolic actions and therapy for diabetes and obesity","volume":"314","author":"Jin","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/bph.13621","article-title":"Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases","volume":"174","author":"Kunnumakkara","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2444393","DOI":"10.1080\/0886022X.2024.2444393","article-title":"Curcumin alleviates renal fibrosis in chronic kidney disease by targeting the circ_0008925-related pathway","volume":"47","author":"An","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2418671","DOI":"10.1155\/2017\/2418671","article-title":"Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis","volume":"2017","author":"Sun","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: Problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"39551","DOI":"10.1038\/srep39551","article-title":"Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction","volume":"6","author":"Abadeh","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s10020-022-00559-5","article-title":"Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications","volume":"28","author":"Mladenov","year":"2022","journal-title":"Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: In vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2010.12.008","article-title":"Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways","volume":"654","author":"Gao","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41598-019-41106-3","article-title":"Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis","volume":"9","author":"Patera","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"F1234","DOI":"10.1152\/ajprenal.00356.2011","article-title":"Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models","volume":"302","author":"Zhou","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/mmr.2021.11834","article-title":"Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.08950621","article-title":"Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial","volume":"17","author":"Nowak","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.17305\/bb.2024.10511","article-title":"Naringenin\u2014A potential nephroprotective agent for diabetic kidney disease: A comprehensive review","volume":"24","year":"2024","journal-title":"Biomol. Biomed."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1210675","DOI":"10.1155\/2021\/1210675","article-title":"Naringenin: A Promising Therapeutic Agent against Organ Fibrosis","volume":"2021","author":"Du","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nutres.2023.08.006","article-title":"Biological activities of naringenin: A narrative review based on in vitro and in vivo studies","volume":"119","year":"2023","journal-title":"Nutr. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/13813455.2018.1529799","article-title":"Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats","volume":"126","author":"Khan","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e13422","DOI":"10.1111\/jfbc.13422","article-title":"Naringenin downregulates inflammation-mediated nitric oxide overproduction and potentiates endogenous antioxidant status during hyperglycemia","volume":"44","author":"Rehman","year":"2020","journal-title":"J. Food Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3109\/13880209.2015.1110599","article-title":"Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-\u03b21 and IL-1 via modulation of oxidative stress","volume":"54","author":"Roy","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/epj.epj_24_17","article-title":"Antioxidant and antihyperglycaemic effects of naringenin arrest the progression of diabetic nephropathy in diabetic rats","volume":"16","author":"Jain","year":"2017","journal-title":"Egypt. Pharm. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1111\/bph.12443","article-title":"Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner","volume":"171","author":"Waheed","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: Food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0278-6915(95)00077-1","article-title":"Review of the biology of Quercetin and related bioflavonoids","volume":"33","author":"Formica","year":"1995","journal-title":"Food Chem. Toxicol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/ptr.8306","article-title":"Quercetin supplementation prevents kidney damage and improves long-term prognosis in hypertensive patients","volume":"38","author":"Zheng","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.13.3.319-328.2006","article-title":"The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-\u03baB system","volume":"13","author":"Nair","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: From antioxidant to nutraceutical","volume":"585","author":"Boots","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2018.05.007","article-title":"Quercetin ameliorates kidney injury and fibrosis by modulating M1\/M2 macrophage polarization","volume":"154","author":"Lu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2327495","DOI":"10.1080\/0886022X.2024.2327495","article-title":"Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"157213","DOI":"10.1016\/j.phymed.2025.157213","article-title":"Quercetin ameliorates renal injury by promoting UCP1-mediated alleviation of lipid accumulation in diabetic kidney disease","volume":"147","author":"Yong","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/ptr.8227","article-title":"Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K\/AKT pathway","volume":"38","author":"Liu","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1039\/C7FO01253E","article-title":"Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model","volume":"9","author":"Zhu","year":"2018","journal-title":"Food Funct."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.kint.2025.05.027","article-title":"Cellular senescence and its association with aldose reductase promote cyst growth in autosomal dominant polycystic kidney disease","volume":"108","author":"Mao","year":"2025","journal-title":"Kidney Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"104751","DOI":"10.1016\/j.phrs.2020.104751","article-title":"Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis","volume":"155","author":"He","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Khunpatee, N., Bhukhai, K., Chatsudthipong, V., and Yuajit, C. (2022). Potential Application of Gambogic Acid for Retarding Renal Cyst Progression in Polycystic Kidney Disease. Molecules, 27.","DOI":"10.3390\/molecules27123837"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/6\/1022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:58:00Z","timestamp":1781769480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/6\/1022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":98,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["life16061022"],"URL":"https:\/\/doi.org\/10.3390\/life16061022","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}